« FDA Approvals - Toshiba Receives FDA Clearance For Vantage Titan MR System (Medical | Main | FDA Approves First Clotting Solution Made Using Recombinant DNA Technology »

Titan Labs expanding its existing Mahad manufacturing facility by investing


Titan Labs expanding its existing Mahad manufacturing facility by investing Rs.3 cr (PharmaBiz)
The Mumbai based pharmaceutical company Titan Laboratories Pvt Ltd is investing Rs 3 crore in the existing manufacturing facility at Mahad on Mumbai-Goa highway.

New findings show Enbrel significantly reduced levels of C-reactive protein (EurekAlert!)
Patients had intermediate to high baseline CRP levels, indicating that psoriasis is a systemic inflammatory disease.
 

©2006 FDA-News.com. All rights reserved.